Delivery Order SPE2DB20D3303-SPE2DB24FZ2V9
Award Date 3/27/24
Potential Completion Date 3/28/24
Potential Value $3.5K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) for the delivery of the pharmaceutical product ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML. The contract has a ceiling value of $2,171.19 and a period of performance through July 11, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract valued at $6,428.06 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract is for the provision of ACTEMRA 162 MG/0.9 ML SYRINGE 0.9ML, a specialty pharmaceutical product, with a delivery date of April 4, 2024. AmerisourceBergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The award, valued at $28,857.21, is a firm fixed price delivery order for the pharmaceutical product ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML. This order was placed under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 that Amerisourcebergen Drug Corp holds with...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,315.44 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the federal government. This order is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the agency to efficiently procure essential medical commodities for military treatment programs and...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The award, valued at $14,603.42, is from the Defense Logistics Agency (DLA) Troop Support Medical for the supply of the pharmaceutical product ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML. The contract is a firm fixed price delivery order with a completion date of February 28, 2024. No set-aside designation was used for this award....
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $29,878.21 firm fixed-price delivery order is for the supply of ACTEMRA 162 MG/0.9 ML syringes. The contract has an ultimate completion date of January 2, 2025. This award is not associated with a set-aside program. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract, valued at $11,288.82, is for the delivery of 400 mg/20 mL vials of the pharmaceutical product ACTEMRA. The contract has a period of performance through March 13, 2024 and does not include any set-aside designations. Amerisourcebergen Drug...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 162 mg/0.9 ml ACTEMRA syringes, with a ceiling value of $10,001.90. It is a Firm Fixed Price Delivery Order contract, with a period of performance through June 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $26,357.99, is for the delivery of ACTEMRA 400 MG/20 ML VIAL 20ML, a specialty medication. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of April 9, 2025. This award is not designated as a set-aside contract. Amerisourcebergen holds a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $7,429.56 Firm Fixed Price Delivery Order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distributor, holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025. This single-award IDC serves as the...